Skip to main content

Table 3 Differentially methylated CpGs

From: DNA methylation in cord blood in association with prenatal depressive symptoms

Group 1

Group 2

Gene

Location

Probe

Log2 fold change

Mean SD

Adjusted p-value

Regulatory feature

Anxiety and prenatal depressive symptoms

Healthy control

ATP Binding Cassette Subfamily F Member 1(ABCF1)

chr6. 30539063

cg05385119

− 0.21

− 3.80 (0.35), − 3,60(0,26)

0.037

Promoter Associated

  

Located upstream of Homo sapiens integrator complex subunit 10 gene (INTS10)

chr8. 19711803

cg00017362

0.18

3.04(0,29), 2,89(0.26)

0.037

 

Healthy controls

Prenatal depressive symptoms with SSRI

Nuclear Factor I A (NFIA)

chr1. 61549982

cg18946602

− 0.91

2.05(0.50), 2.82 (0.96)

0.005

 
  

Chromosome 2 open reading frame 40 (C2orf40)

chr2 106682209

cg17161250

− 0.71

− 3.83(0.38), − 3.14(1.10)

0.004

Unclassified cell-type specific

  

Immunoglobulin Superfamily Member 11 (IGSF11)

chr3 118864895

cg20675391

− 0.70

3.74(0.43), 4.35(1.11)

0.024

Unclassified

  

Cereblon (CRBN)

chr3 3221595

cg20787969

− 0.57

− 4.39(0.26), − 3.83(1.39)

0.020

Promoter Associated

  

Cyclin-Dependent Kinase 11B (CDK11B)

chr1 1655867

cg00669623

− 0.29

− 3.32 (0.12), − 3.04(0.74)

0.021

Promoter Associated

  

WD Repeat Containing. Antisense To TP73 (WRAP73)

chr1 3551807

cg04386615

− 0.54

3.64(0.37), 4.15(0.46)

0.048

 
  

G Protein-Coupled Receptor Kinase 4 (GRK4)

chr4 3033304

cg03178823

0.43

2.47(0.20), 1.99(0.93)

0.010

 
  

MyoD Family Inhibitor Domain Containing (MDFIC)

chr7 114562316

cg02239805

0.44

− 1.52(0.09), − 1.96(1.42)

0.010

Promoter Associated

  

Potassium Voltage-Gated Channel Modifier Subfamily S Member 2 (KCNS2)

chr8 99441950

cg02143496

0.49

3.19(0.29), 2.71(0.88)

0.010

 
  

LRRN4 C-Terminal Like (LRRN4CL)

chr11 62455369

cg03353995

0.49

− 2,38(0.32), − 2,80(0.33)

0.041

 
  

Mitogen-Activated Protein Kinase Kinase Kinase Kinase 5 (MAP4K5)

chr14 50999680

cg21062897

0.49

− 0.85 (0.15),—1.33(1.61)

0.018

Promoter Associated

   

chr3 169476270

cg16056894

0.56

− 1.33(0.35), − 1.82(0.67)

0.029

 
  

SOX2 Overlapping Transcript (SOX2OT)

chr3 181444989

cg17202313

0.57

− 3.76(0.36), − 4.24(0.70)

0.030

Unclassified cell-type specific

  

Chromosome 10 open reading frame 11 (C10orf11)

chr10 77871958

cg24280832

0.98

1.54(0.39), 0.51(1.72)

 < 0.000

 
  

Nuclear Factor I A (NFIA)

chr1 61549982

cg18946602

− 0.80

2.11(0.56), 2.82(0.95)

0.041

 

Prenatal depressive symptoms without SSRI

Prenatal depressive symptoms with SSRI

Chromosome 2 open reading frame 40 (C2orf40)

chr2 106682209

cg17161250

− 0.72

− 3.87(0.41), − 3.14(1.10)

0.003

Unclassified cell-type specific

  

Cereblon (CRBN)

chr3 3221595

cg20787969

− 0.57

− 4.38(0.25), − 3.83(1.39)

0.026

Promoter Associated

  

Primary Ciliary Dyskinesia Protein 1 (PCDP1)

chr2 120301847

cg23747904

− 0.55

− 4.17(0.27), − 3.67(1.37)

0.040

 
  

WD Repeat Containing. Antisense To TP73 (WRAP73)

chr1 3551807

cg04386615

− 0.54

3.66(0.33), 4.15(0.46)

0.040

 
   

chr1 1712021

cg23678594

− 0.34

− 4.31(0.19), − 3.98(0.43)

0.038

Promoter Associated

  

Cyclin-Dependent Kinase 11B (CDK11B)

chr1 1655867

cg00669623

− 0.29

− 3.32(0.13), − 3.05(0.73)

0.037

Promoter Associated

  

Solute Carrier Family 16 Member 11 (SLC16A11)

chr17 6947200

cg15639045

− 0.28

− 3.54(0.14), − 3.26(0.49)

0.011

 
  

Uncharacterized LOC284930

chr22 48182596

cg00331486

0.36

1.69(0.23), 1.35(0.59)

0.043

 
  

MyoD Family Inhibitor Domain Containing (MDFIC)

chr7 114562316

cg02239805

0.45

− 1.51(0.08), 1.96(1.42)

0.007

Promoter Associated

  

G Protein-Coupled Receptor Kinase 4 (GRK4)

chr4 3033304

cg03178823

0.45

2.47(0.21), 1.99(0.93)

0.004

 
  

Mitogen-Activated Protein Kinase Kinase Kinase Kinase 5 (MAP4K5)

chr14 50999680

cg21062897

0.48

− 0.90(0.15), − 1.33(1.61)

0.036

Promoter Associated

   

chr3 169476270

cg16056894

0.56

− 1.33(0.36), − 1.82(0.67)

0.038

 
  

Chromosome 10 open reading frame 11 (C10orf11)

chr10 77871958

cg24280832

0.94

1.48(0.39), 0.51(1.72)

 < 0.000

 
  1. Location: chromosome and genomic position. Group difference in DNA methylation in specific CpGs are presented as log2 fold change (log2 (M-value group1/M-value group 2)) between the groups, meaning that a negative log2 fold changes means lower DNA methylation in group 1. Mean SD = mean standard deviation for group 1, group 2
  2. chromosome (chr), standard deviation (SD)